Paras Healthcare IPO was subscribed 0.34 times on the second day of bidding, according to the supplied subscription data, as retail investor demand outpaced participation from institutional and non-institutional investors. The ₹1,450-crore public issue will remain open for subscription until October 23.
The issue received bids for 41.23 lakh shares against 1.21 crore shares on offer. The retail category was subscribed 1.31 times, while the non-institutional investor (NII) and qualified institutional buyer (QIB) portions were subscribed 0.25 times and 0.06 times, respectively.
Paras Healthcare IPO subscription: Key takeaways
Retail investors lead: The retail category received bids for 28.69 lakh shares against 21.97 lakh shares reserved, taking subscription to 1.31 times.
Institutional demand remains weak: QIBs bid for 4.28 lakh shares against an allocation of 65.91 lakh shares.
NII participation remains limited: The category received bids for 8.27 lakh shares against 32.95 lakh shares offered.
Smaller NII bids outperform larger applications: The ₹2 lakh–₹10 lakh subcategory was subscribed 0.31 times, compared with 0.22 times for applications above ₹10 lakh.
Paras Healthcare IPO GMP today
The grey market premium (GMP) for Paras Healthcare IPO was reported at ₹25 per share on October 22. Against the upper issue price of ₹693, this points to an indicative listing price of ₹718, representing a potential premium of 3.61%.
The premium has moderated from earlier reported levels, indicating a more cautious grey market sentiment ahead of the issue's closing date. However, grey market transactions are unofficial, and GMP movements do not necessarily translate into corresponding listing gains.
Indicator | Latest reported figure |
|---|---|
GMP | ₹25 |
Upper issue price | ₹693 |
Implied listing price | ₹718 |
Indicative premium | 3.61% |
Issue closing date | October 23, 2026 |
What to watch on Day 3
The final subscription day will be important for determining whether institutional and NII demand improves enough to lift overall subscription. Retail participation has already crossed the one-times mark, but the issue remains undersubscribed overall in the supplied snapshot.
Investors tracking the IPO should monitor the final exchange subscription figures alongside changes in GMP. The closing subscription level and eventual listing price may differ materially from current estimates.
Disclaimer: GMP is an unofficial market indicator and does not guarantee listing gains. This report is for informational purposes only and is not investment advice.
